Search All Jobs

Showing 10 of 10 Jobs

Manager – Manufacturing Materials Logistics - Cell Therapy

$92.6k - $138.9k/yr

Gaithersburg, MD, USA

Director – Global Brand Planner

Chennai, Tamil Nadu, India

Cell Therapy Supply Chain Logistics – Sr Analyst

$85k - $127.5k/yr

Gaithersburg, MD, USA

Lead Consultant - Product Expert - Supply Chain Planning

Chennai, Tamil Nadu, India

Lead Consultant - Data Ops Engineer

Chennai, Tamil Nadu, India

External Operations Coordinator

Chennai, Tamil Nadu, India

International Distribution Coordinator

Chennai, Tamil Nadu, India

Senior Specialist - Clinical Logistics

$92.6k - $138.9k/yr

Gaithersburg, MD, USA

Lean Digital Partner

$114.3k - $171.4k/yr

Frederick, MD, USA

Process Optimisation Manager

Chennai, Tamil Nadu, India

Full-Time

Manager – Manufacturing Materials Logistics

Cell Therapy

Confirmed live in the last 24 hours

AstraZeneca

AstraZeneca

10,001+ employees

Develops and commercializes prescription medicines

Compensation Overview

$92.6k - $138.9k/yr

+ Short-term Incentive Bonus + Equity-based Long-term Incentive Program

Senior

Gaithersburg, MD, USA

Category
Supply Chain Management
Transportation & Distribution
Operations & Logistics
Biology & Biotech
Required Skills
Power BI
SAP Products
Tableau
Oracle
Data Analysis
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • BS/BA or equivalent in Supply Chain, Life Sciences, Business, or Data Analytics
  • Minimum 5 years of experience in Cell Therapy Logistics or Clinical Supply Chain within the pharmaceutical or biotech industry
  • Proficiency in SAP/Oracle, Power BI/Tableau, Smartsheet, and advanced Excel (pivot tables, macros)
  • Analytical mindset with the ability to interpret data and present complex information
  • Stakeholder management skills; comfortable working with finance, clinical, manufacturing, quality, and regulatory teams
Responsibilities
  • Oversee logistics & track high-value global shipments of clinical & commercial trial manufacturing materials (e.g., viral vectors, plasmids, cell banks)
  • Ensure compliance with international trade regulations (GxP, IATA, DOT, Customs)
  • Manage temperature-sensitive logistics, including risk assessments, contingency planning & deviation management
  • Collaborate with internal & external manufacturing teams to guarantee accurate shipping documentation
  • Identify & lead initiatives to enhance logistics workflows, reduce costs & ensure compliance
  • Create & update SOPs related to shipping, documentation & analytics processes
  • Support internal/external audits
  • Cultivate relationships with third-party logistics providers, raw material suppliers, specialty couriers & depots used for efficient transportation & storage
  • Oversee lane mapping & courier performance while implementing contingency plans to mitigate potential delays
  • Monitor key courier performance metrics, including temperature excursions & customs clearance efficiencies
  • Support annual budgeting & financial forecasting for global logistics operations
  • Analyze & track logistics expenditures to identify cost-saving opportunities
  • Provide regular reports on shipping costs, vendor performance & budget adherence
  • Collaborate with manufacturing, clinical operations & finance to align logistics capacity with trial demand (S&OP & S&OE Support)
  • Design & implement KPIs to measure logistics performance (on-time delivery, cost per shipment, temperature excursion rates)
  • Create dashboards & reports (PowerPoint, Excel, Power BI/Tableau) for senior leadership
  • Help establish new manufacturing lanes related to cell therapy logistics of critical manufacturing materials
  • Be a backup for clinical logistics specialists in overseeing vein-to-vein activities
  • Lead cross-functional meetings to align objectives across departments
  • Identify potential risks & recommend process improvements
Desired Qualifications
  • Certifications (e.g., CSCP, CPIM, Lean, Six Sigma) are a plus
  • Background in cold chain logistics, 3PL management, clinical and commercial logistics, and cell & gene therapies

AstraZeneca develops and sells prescription medicines, focusing on three main areas: Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Their products are created through extensive research and development, which includes clinical trials and regulatory approvals. Unlike competitors, AstraZeneca emphasizes collaboration through its Open Innovation program and the A.Catalyst Network, connecting health innovation hubs worldwide. The company's goal is to advance healthcare by providing effective treatments for serious diseases.

Company Size

10,001+

Company Stage

IPO

Headquarters

Cambridge, United Kingdom

Founded

1913

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven drug discovery enhances AstraZeneca's R&D efficiency and innovation.
  • Real-world evidence supports AstraZeneca's drug efficacy and safety demonstrations.
  • Personalized medicine aligns with AstraZeneca's focus on precision therapies.

What critics are saying

  • Class-action lawsuit over Soliris could lead to legal costs and reputational damage.
  • AI tool for breast cancer screening may face challenges in minority representation.
  • Foreign investment regulations in France may impact AstraZeneca's Dunkirk expansion.

What makes AstraZeneca unique

  • AstraZeneca excels in oncology, cardiovascular, and respiratory therapeutic areas.
  • The A.Catalyst Network fosters global collaboration and innovation in healthcare.
  • Open Innovation program accelerates drug discovery by sharing compounds and technologies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Flexible Work Hours

Company News

Cision
Apr 22nd, 2025
Enhertu Combination Improved Pfs In 1L Her2+ Mbc

Enhertu combination improved PFS in 1L HER2+ mBC

Life Sciences IP Review
Apr 17th, 2025
AstraZeneca unit faces class-action suit over alleged Soliris monopoly

AstraZeneca unit faces class-action suit over alleged soliris monopoly.

Our Health Needs
Apr 11th, 2025
Study: Racial, ethnic minorities are underrepresented in AI mammogram interpretation

In 2024, AI biotech company Owkin partnered with pharma giant AstraZeneca to develop an AI-powered tool designed to pre-screen for gBRCA mutations (gBRCAm) in breast cancer directly from digitized pathology slides.

Medical Update Online
Apr 11th, 2025
AstraZeneca showcases progress in immunisation and real-world evidence addressing global infectious disease burden at ESCMID Global 2025

AstraZeneca showcases progress in immunisation and real-world evidence addressing global infectious disease burden at ESCMID Global 2025.

Cision
Apr 11th, 2025
Result Of Agm

11 April 2025Results of Annual General Meeting held on 11 April 2025AstraZeneca PLC announced the results of the voting at its Annual General Meeting (AGM) today. As proposed in the Notice of AGM, all Resolutions were decided by poll vote. Resolutions 9 - 12 were passed as special resolutions; all other resolutions were passed as ordinary resolutions.Resolution. Votes for. % of votes cast